APA (7th ed.) Citation

C, L. T., X, L., F, N., S, D., S, S., V, C., . . . Z, T. (2026). Intratumoral Radioenhancer Nanoparticle NBTXR3 Followed by Radiotherapy in Head and Neck Cancer: A Phase 1 Dose-Expansion Nonrandomized Clinical Trial. JAMA otolaryngology-- head & neck surgery, 152(3), 284. https://doi.org/10.1001/jamaoto.2025.4939

Chicago Style (17th ed.) Citation

C, Le Tourneau, et al. "Intratumoral Radioenhancer Nanoparticle NBTXR3 Followed by Radiotherapy in Head and Neck Cancer: A Phase 1 Dose-Expansion Nonrandomized Clinical Trial." JAMA Otolaryngology-- Head & Neck Surgery 152, no. 3 (2026): 284. https://doi.org/10.1001/jamaoto.2025.4939.

MLA (9th ed.) Citation

C, Le Tourneau, et al. "Intratumoral Radioenhancer Nanoparticle NBTXR3 Followed by Radiotherapy in Head and Neck Cancer: A Phase 1 Dose-Expansion Nonrandomized Clinical Trial." JAMA Otolaryngology-- Head & Neck Surgery, vol. 152, no. 3, 2026, p. 284, https://doi.org/10.1001/jamaoto.2025.4939.